Document is current
Any future updates will be listed below
-
Authors
Leighow, Scott M.
Reynolds, Joshua A. https://orcid.org/0000-0001-6680-5993
Sokirniy, Ivan https://orcid.org/0000-0002-1846-5469
Yao, Shun
Yang, Zeyu
Inam, Haider
Wodarz, Dominik
Archetti, Marco
Pritchard, Justin R. https://orcid.org/0000-0001-7749-4473
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1U01CA265709, 1U01CA265709)
- License Information
-
More Information
Article History
Received: 30 May 2023
Accepted: 6 May 2024
First Online: 4 July 2024
Competing interests
: J.R.P. is a co-founder of Theseus Pharmaceuticals and holds equity in Theseus Pharmaceuticals. J.R.P. consults for and holds equity in MOMA Therapeutics. J.R.P. and S.M.L. are co-founders of Red Ace Bio. J.R.P. and S.M.L. have filed for patent protection of the work described in the manuscript.
